177 related articles for article (PubMed ID: 3080846)
1. Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations.
Kauppila A; Heikkinen J; Viinikka L
Acta Endocrinol (Copenh); 1986 Jan; 111(1):10-6. PubMed ID: 3080846
[TBL] [Abstract][Full Text] [Related]
2. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
Jeske W
Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral and intravenous TRH and metoclopramide on PRL and TSH secretion in women.
Kauppila A; Ylikorkala O
Clin Endocrinol (Oxf); 1982 Dec; 17(6):617-23. PubMed ID: 6819904
[TBL] [Abstract][Full Text] [Related]
4. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
Barbarino A; de Marinis L; Menini E; Anile C; Maira G
Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
[TBL] [Abstract][Full Text] [Related]
5. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
[TBL] [Abstract][Full Text] [Related]
6. Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism.
Röjdmark S; Carlsson A
Acta Endocrinol (Copenh); 1985 Oct; 110(2):221-6. PubMed ID: 2998132
[TBL] [Abstract][Full Text] [Related]
7. Catecholamines and pituitary function. IV. Effects of low-dose dopamine infusion and long-term bromocriptine treatment on the abnormal thyrotroph (TSH) dynamics in patients with pathological hyperprolactinaemia.
Nicoletti I; Filipponi P; Fedeli L; Ambrosi F; Giammartino C; Spinozzi F; Santeusanio F
Acta Endocrinol (Copenh); 1986 Feb; 111(2):154-61. PubMed ID: 3082094
[TBL] [Abstract][Full Text] [Related]
8. Prolactin response to metoclopramide and thyrotropin-releasing hormone in normoprolactinemic and hyperprolactinemic women: a comparison of diagnostic validity.
Bussen S; Brosemann N; Steck T
Gynecol Endocrinol; 1996 Apr; 10(2):83-90. PubMed ID: 8701791
[TBL] [Abstract][Full Text] [Related]
9. Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.
MacGregor C; Maldonado D; Canales ES; Soria J; Zárate A
Acta Obstet Gynecol Scand; 1977; 56(4):333-6. PubMed ID: 414510
[TBL] [Abstract][Full Text] [Related]
10. Are fasting-induced effects on thyrotropin and prolactin secretion mediated by dopamine?
Röjdmark S
J Clin Endocrinol Metab; 1983 Jun; 56(6):1266-70. PubMed ID: 6404923
[TBL] [Abstract][Full Text] [Related]
11. Metoclopramide increases prolactin release and milk secretion in puerperium without stimulating the secretion of thyrotropin and thyroid hormones.
Kauppila A; Kivinen S; Ylikorkala O
J Clin Endocrinol Metab; 1981 Mar; 52(3):436-9. PubMed ID: 6780593
[TBL] [Abstract][Full Text] [Related]
12. Effects of thyrotropin-releasing hormone and metoclopramide on PRL secretion in normally cycling and amenorrheic alcoholic women.
Vescovi PP; Coiro V
Drug Alcohol Depend; 1997 Apr; 45(1-2):115-9. PubMed ID: 9179513
[TBL] [Abstract][Full Text] [Related]
13. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
[TBL] [Abstract][Full Text] [Related]
14. Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
Ho KY; Smythe GA; Compton PJ; Lazarus L
Aust N Z J Med; 1985 Apr; 15(2):213-9. PubMed ID: 3927887
[TBL] [Abstract][Full Text] [Related]
15. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
Hirvonen E; Ranta T; Seppäla M
J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
[TBL] [Abstract][Full Text] [Related]
16. Prolactin secretion in myotonic dystrophy.
Marinković Z; Prelevic G; Han R; Würzburger M; Todorovic S
Exp Clin Endocrinol; 1990 Dec; 96(3):247-52. PubMed ID: 2128051
[TBL] [Abstract][Full Text] [Related]
17. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
[TBL] [Abstract][Full Text] [Related]
18. [Study on the neuroendocrinological control of prolactin release in early puerperium].
Kubota T; Kamada S; Tsuzuki H; Tei A; Saito M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1108-14. PubMed ID: 3112295
[TBL] [Abstract][Full Text] [Related]
19. Prolactin and TSH responses to both domperidone and TRH in normal and hyperprolactinaemic women after dopamine synthesis blockade.
Ghigo E; Goffi S; Molinatti GM; Camanni F; Massara F
Clin Endocrinol (Oxf); 1985 Aug; 23(2):155-60. PubMed ID: 3931942
[TBL] [Abstract][Full Text] [Related]
20. The prolactin-releasing mechanism of the hypothalamo-pituitary axis in pregnancy.
Kubota T; Yaoi Y; Nagae M; Kumasaka T; Saito M
Fertil Steril; 1984 Nov; 42(5):724-9. PubMed ID: 6436068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
